23
23.00 (-0.49%)
As of Feb 09, 2023
REGENXBIO Inc. [RGNX]
Source:
Company Overview
Regenxbio Inc is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Our investigational gene therapies are designed to deliver functional genes to address genetic defects in cells, enabling the production of therapeutic proteins or antibodies that are intended to impact disease.
Country | United States |
Headquarters | rockville, maryland |
Phone Number | 240-552-8181 |
Industry | manufacturing |
CEO | Kenneth T. Mills |
Website | www.regenxbio.com |